These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27484623)

  • 1. A CRISPR-Cas9 sex-ratio distortion system for genetic control.
    Galizi R; Hammond A; Kyrou K; Taxiarchi C; Bernardini F; O'Loughlin SM; Papathanos PA; Nolan T; Windbichler N; Crisanti A
    Sci Rep; 2016 Aug; 6():31139. PubMed ID: 27484623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y chromosome shredding in Anopheles gambiae: Insight into the cellular dynamics of a novel synthetic sex ratio distorter.
    Vitale M; Kranjc N; Leigh J; Kyrou K; Courty T; Marston L; Grilli S; Crisanti A; Bernardini F
    PLoS Genet; 2024 Jun; 20(6):e1011303. PubMed ID: 38848445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered sex ratio distortion by X-shredding in the global agricultural pest Ceratitis capitata.
    Meccariello A; Krsticevic F; Colonna R; Del Corsano G; Fasulo B; Papathanos PA; Windbichler N
    BMC Biol; 2021 Apr; 19(1):78. PubMed ID: 33863334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms regulating synthetic sex ratio distortion in the
    Haghighat-Khah RE; Sharma A; Wunderlich MR; Morselli G; Marston LA; Bamikole C; Hall A; Kranjc N; Taxiarchi C; Sharakhov I; Galizi R
    Pathog Glob Health; 2020 Oct; 114(7):370-378. PubMed ID: 33043870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mosquito X-chromosomes reveals complex transmission dynamics of sex ratio distorting gene drives.
    Haber DA; Arien Y; Lamdan LB; Alcalay Y; Zecharia C; Krsticevic F; Yonah ES; Avraham RD; Krzywinska E; Krzywinski J; Marois E; Windbichler N; Papathanos PA
    Nat Commun; 2024 Jun; 15(1):4983. PubMed ID: 38862555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the X chromosome during spermatogenesis induces Y chromosome transmission ratio distortion and early dominant embryo lethality in Anopheles gambiae.
    Windbichler N; Papathanos PA; Crisanti A
    PLoS Genet; 2008 Dec; 4(12):e1000291. PubMed ID: 19057670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic and literature assessment of toxicity and allergenicity of a CRISPR-Cas9 engineered gene drive to control Anopheles gambiae the mosquito vector of human malaria.
    Qureshi A; Connolly JB
    Malar J; 2023 Aug; 22(1):234. PubMed ID: 37580703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the potential of X chromosome shredding for mouse genetic biocontrol.
    Bunting MD; Godahewa GI; McPherson NO; Robertson LJ; Gierus L; Piltz SG; Edwards O; Tizard M; Thomas PQ
    Sci Rep; 2024 Jun; 14(1):13466. PubMed ID: 38866815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell profiling of Anopheles gambiae spermatogenesis defines the onset of meiotic silencing and premeiotic overexpression of the X chromosome.
    Page N; Taxiarchi C; Tonge D; Kuburic J; Chesters E; Kriezis A; Kyrou K; Game L; Nolan T; Galizi R
    Commun Biol; 2023 Aug; 6(1):850. PubMed ID: 37582841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming evolved resistance to population-suppressing homing-based gene drives.
    Marshall JM; Buchman A; Sánchez C HM; Akbari OS
    Sci Rep; 2017 Jun; 7(1):3776. PubMed ID: 28630470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The creation and selection of mutations resistant to a gene drive over multiple generations in the malaria mosquito.
    Hammond AM; Kyrou K; Bruttini M; North A; Galizi R; Karlsson X; Kranjc N; Carpi FM; D'Aurizio R; Crisanti A; Nolan T
    PLoS Genet; 2017 Oct; 13(10):e1007039. PubMed ID: 28976972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks.
    van Overbeek M; Capurso D; Carter MM; Thompson MS; Frias E; Russ C; Reece-Hoyes JS; Nye C; Gradia S; Vidal B; Zheng J; Hoffman GR; Fuller CK; May AP
    Mol Cell; 2016 Aug; 63(4):633-646. PubMed ID: 27499295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the performance of pooled CRISPR-Cas9 drop-out screening.
    Cross BC; Lawo S; Archer CR; Hunt JR; Yarker JL; Riccombeni A; Little AS; McCarthy NJ; Moore JD
    Sci Rep; 2016 Aug; 6():31782. PubMed ID: 27545104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Species Y Chromosome Function Between Malaria Vectors of the
    Bernardini F; Galizi R; Wunderlich M; Taxiarchi C; Kranjc N; Kyrou K; Hammond A; Nolan T; Lawniczak MNK; Papathanos PA; Crisanti A; Windbichler N
    Genetics; 2017 Oct; 207(2):729-740. PubMed ID: 28860320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity.
    Tycko J; Myer VE; Hsu PD
    Mol Cell; 2016 Aug; 63(3):355-70. PubMed ID: 27494557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the genomic landscape of CRISPR-Cas9 cleavage.
    Cameron P; Fuller CK; Donohoue PD; Jones BN; Thompson MS; Carter MM; Gradia S; Vidal B; Garner E; Slorach EM; Lau E; Banh LM; Lied AM; Edwards LS; Settle AH; Capurso D; Llaca V; Deschamps S; Cigan M; Young JK; May AP
    Nat Methods; 2017 Jun; 14(6):600-606. PubMed ID: 28459459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous genetic recording with self-targeting CRISPR-Cas in human cells.
    Perli SD; Cui CH; Lu TK
    Science; 2016 Sep; 353(6304):. PubMed ID: 27540006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
    Eyquem J; Mansilla-Soto J; Giavridis T; van der Stegen SJ; Hamieh M; Cunanan KM; Odak A; Gönen M; Sadelain M
    Nature; 2017 Mar; 543(7643):113-117. PubMed ID: 28225754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 nuclear dynamics and target recognition in living cells.
    Ma H; Tu LC; Naseri A; Huisman M; Zhang S; Grunwald D; Pederson T
    J Cell Biol; 2016 Aug; 214(5):529-37. PubMed ID: 27551060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.
    Robinson-Hamm JN; Gersbach CA
    Hum Genet; 2016 Sep; 135(9):1029-40. PubMed ID: 27542949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.